Ginkoum capsules 40mg, No. 60

• disorders of cerebral circulation, accompanied by disorders of attention, memory impairment, decreased intellectual abilities, dizziness, tinnitus, headache;

• violations of peripheral circulation and microcirculation, accompanied by a feeling of coldness in the extremities, pain when walking, painful cramps and heaviness in the legs, paresthesias;

• dysfunction of the inner ear, manifested by dizziness, unsteady gait and tinnitus.

If a doctor has not recommended a different dosage regimen, adhere to the following recommendations for taking the drug:
For symptomatic treatment of cerebrovascular accidents:
1-2 capsules (respectively 40-80 mg of standardized dry extract of ginkgo biloba) 3 times a day. The duration of the course of treatment is at least 8 weeks.

For peripheral circulatory disorders:
1 capsule (respectively 40 mg of standardized dry extract of ginkgo biloba) 3 times a day or 2 capsules (respectively 80 mg of standardized dry extract of ginkgo biloba) 2 times a day. The duration of the course of treatment is at least 6 weeks.
For vascular or involutional pathology of the inner ear:
1 capsule (respectively 40 mg of standardized dry extract of ginkgo biloba) 3 times a day or 2 capsules (respectively 80 mg of standardized dry extract of ginkgo biloba) 2 times a day.
The capsules should be taken with a small amount of liquid, with or without food.
If the drug was missed or an insufficient amount was taken, the subsequent administration of it should be carried out as indicated in this instruction without any changes.

(for one capsule)

Active ingredient: ginkgo biloba extract dry, standardized with the content of flavonol glycosides 22.0-27.0% and terpene lactones 570-12.0% - 0.040 g
Auxiliary components: microcrystalline cellulose - 0.109 g, calcium stearate - 0.001 g, hard capsules gelatinous (components of the capsule body: iron oxide black E 172, iron oxide red E 172, titanium dioxide E 171, iron oxide yellow E 172, gelatin; capsule lid components: iron oxide black E 172, iron oxide red E 172, titanium dioxide E 171, iron oxide yellow E 172, gelatin).

Hypersensitivity to the components, decreased blood clotting, erosive gastritis, peptic ulcer of the stomach and duodenum in the acute stage, acute cerebrovascular accidents, pregnancy, lactation, childhood (up to 12 years) (due to the lack of sufficient clinical data).

Trade name of the drug

GINCOUMЃ

Dosage form

Capsules

Composition (for one capsule)

Active ingredient: ginkgo biloba extract dry, standardized with the content of flavonol glycosides 22.0-27.0% and terpene lactones 570-12.0% - 0.040 g
Auxiliary components: microcrystalline cellulose - 0.109 g, calcium stearate - 0.001 g, hard capsules gelatinous (components of the capsule body: iron oxide black E 172, iron oxide red E 172, titanium dioxide E 171, iron oxide yellow E 172, gelatin; capsule lid components: iron oxide black E 172, iron oxide red E 172, titanium dioxide E 171, iron oxide yellow E 172, gelatin).

Description

Hard gelatin capsules from light brown to dark brown, size No. 1. The contents of the capsules are powder or partially caked powder from yellow to light brown with whitish and dark inclusions.

Pharmacotherapeutic group

An angioprotective agent of plant origin.

Pharmacological properties

Improves cerebral circulation and the supply of oxygen and glucose to the brain. It has a vasoregulatory effect mainly on the vessels of the brain. Improves blood flow, prevents platelet aggregation. Prevents the formation of free radicals.

Indications for use

• disorders of cerebral circulation, accompanied by disorders of attention, memory impairment, decreased intellectual abilities, dizziness, tinnitus, headache;

• violations of peripheral circulation and microcirculation, accompanied by a feeling of coldness in the extremities, pain when walking, painful cramps and heaviness in the legs, paresthesias;

• dysfunction of the inner ear, manifested by dizziness, unsteady gait and tinnitus.

Contraindications

Hypersensitivity to the components, decreased blood clotting, erosive gastritis, peptic ulcer of the stomach and duodenum in the acute stage, acute cerebrovascular accidents, pregnancy, lactation, childhood (up to 12 years) (due to the lack of sufficient clinical data).

Method of administration and dosage

If a doctor has not recommended a different dosage regimen, adhere to the following recommendations for taking the drug:
For symptomatic treatment of cerebrovascular accidents:
1-2 capsules (respectively 40-80 mg of standardized dry extract of ginkgo biloba) 3 times a day. The duration of the course of treatment is at least 8 weeks.

For peripheral circulatory disorders:
1 capsule (respectively 40 mg of standardized dry extract of ginkgo biloba) 3 times a day or 2 capsules (respectively 80 mg of standardized dry extract of ginkgo biloba) 2 times a day. The duration of the course of treatment is at least 6 weeks.
For vascular or involutional pathology of the inner ear:
1 capsule (respectively 40 mg of standardized dry extract of ginkgo biloba) 3 times a day or 2 capsules (respectively 80 mg of standardized dry extract of ginkgo biloba) 2 times a day.
The capsules should be taken with a small amount of liquid, with or without food.
If the drug was missed or an insufficient amount was taken, the subsequent administration of it should be carried out as indicated in this instruction without any changes.

Side effects

Allergic reactions (redness, swelling of the skin, itching), dyspepsia, headache, decreased blood clotting, hearing impairment, dizziness are possible.

If you observe any undesirable effects while taking the drug, please report them to your doctor.

Overdose

Cases of drug overdose have not been reported to date.

Interaction with other medicinal products

It is not excluded that the drug GINCOUMЃ interacts with drugs that have an anticoagulant effect.

special instructions

Attention! All regulations must be strictly followed!
In the event of a sudden deterioration or loss of hearing, seek medical attention immediately. A doctor's consultation is also necessary for frequent dizziness and tinnitus.

Release form

Capsules 40 mg. 15 capsules in a blister strip packaging. For 30, 60, 90 capsules in polymer jars. 2, 4, 6 blister packs or each jar, together with instructions for use, are placed in a cardboard box.

Storage conditions

In a dry, dark place at a temperature not exceeding 25 ? C.
Out of the reach of children.

Shelf life

3 years.
Do not use the drug after the expiration date.

Conditions of dispensing from pharmacies

Without recipe.